MedEquities Realty Trust Inc (NYSE:MRT) has earned an average rating of “Hold” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $12.17.
A number of equities research analysts have issued reports on the stock. Royal Bank of Canada reiterated a “sector perform” rating and set a $11.00 target price (down from $12.00) on shares of MedEquities Realty Trust in a report on Wednesday, May 23rd. B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Monday, May 14th. KeyCorp reduced their target price on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Monday, April 16th. ValuEngine lowered shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. Finally, JMP Securities set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Friday, May 11th.
In other news, Director Bluemountain Capital Managemen sold 9,948 shares of the firm’s stock in a transaction on Tuesday, May 29th. The shares were sold at an average price of $10.34, for a total value of $102,862.32. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold a total of 363,688 shares of company stock worth $3,756,271 over the last 90 days. Company insiders own 3.00% of the company’s stock.
Institutional investors and hedge funds have recently made changes to their positions in the company. MetLife Investment Advisors LLC acquired a new stake in shares of MedEquities Realty Trust in the 4th quarter valued at $120,000. Barclays PLC raised its holdings in shares of MedEquities Realty Trust by 252.2% in the 1st quarter. Barclays PLC now owns 16,016 shares of the financial services provider’s stock valued at $168,000 after purchasing an additional 11,469 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of MedEquities Realty Trust by 221.9% in the 1st quarter. JPMorgan Chase & Co. now owns 19,898 shares of the financial services provider’s stock valued at $210,000 after purchasing an additional 13,717 shares in the last quarter. UBS Group AG raised its holdings in shares of MedEquities Realty Trust by 52.3% in the 1st quarter. UBS Group AG now owns 23,234 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 7,978 shares in the last quarter. Finally, Allianz Asset Management GmbH acquired a new stake in shares of MedEquities Realty Trust in the 1st quarter valued at $254,000. Institutional investors and hedge funds own 93.53% of the company’s stock.
MedEquities Realty Trust opened at $11.02 on Friday, Marketbeat Ratings reports. The company has a market cap of $351.39 million, a price-to-earnings ratio of 9.42 and a beta of -0.16. MedEquities Realty Trust has a 52-week low of $9.67 and a 52-week high of $12.88.
MedEquities Realty Trust (NYSE:MRT) last released its earnings results on Thursday, May 10th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.14). The business had revenue of $16.72 million for the quarter, compared to analyst estimates of $16.41 million. MedEquities Realty Trust had a return on equity of 6.17% and a net margin of 34.63%. equities analysts predict that MedEquities Realty Trust will post 1.2 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 5th. Stockholders of record on Tuesday, May 22nd were issued a $0.21 dividend. The ex-dividend date was Monday, May 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.62%. MedEquities Realty Trust’s payout ratio is 73.68%.
About MedEquities Realty Trust
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.